Scilex Petitions FDA to Pull Unapproved Lidocaine Patches

Drug Industry Daily
A A
Scilex Pharmaceuticals urged the FDA to remove unapproved lidocaine patches from the market and issue guidance on the marketing of such products.

To View This Article:

Login

Subscribe To Drug Industry Daily